Home
Scholarly Works
A Phase I Evaluation of Oral CI-1033 in...
Journal article

A Phase I Evaluation of Oral CI-1033 in Combination with Paclitaxel and Carboplatin as First-Line Chemotherapy in Patients with Advanced Non-small Cell Lung Cancer

Authors

Chiappori AA; Ellis PM; Hamm JT; Bitran JD; Eiseman I; Lovalvo J; Burnett D; Olson S; Lenehan P; Zinner RG

Journal

Journal of Thoracic Oncology, Vol. 1, No. 9, pp. 1010–1019

Publisher

Elsevier BV

Publication Date

November 1, 2006

DOI

10.1016/s1556-0864(15)31635-x

ISSN

1556-0864

Contact the Experts team